{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T03:23:20Z","timestamp":1787628200622,"version":"build-2736575974"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010252","name":"\u015al\u0105ski Uniwersytet Medyczny w Katowicach","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Epithelial-to-mesenchymal transition (EMT)-driven phenotypic plasticity promotes bladder cancer (BC) progression and therapy resistance. While EMT has been primarily associated with transcriptional reprogramming, the contribution of post-transcriptional mechanisms, particularly alternative splicing regulation, remains insufficiently explored. This study aimed to investigate the clinical significance and mechanistic role of epithelial splicing regulatory protein 2 (ESRP2) in BC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Integrative analyses of publicly available transcriptomic datasets (TCGA and GEO) were performed to evaluate the prognostic value of ESRP2 and its association with epithelial and mesenchymal phenotypes in BC cell lines. Functional assays, including ESRP2 knockdown and overexpression, were conducted to assess its impact on EMT marker expression, cellular behavior, and stemness-related features such as clonogenicity, spheroid formation, and cell surface marker expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>High ESRP2 expression correlated with improved patient survival and an epithelial-like phenotype in BC models. ESRP2 loss induced mesenchymal marker expression and increased cell motility, whereas ESRP2 overexpression restored epithelial morphology, reduced migration, and suppressed anchorage-independent growth. Flow cytometry revealed no significant changes in CD44 expression but showed a moderate increase in CD133+ cells following ESRP2 overexpression, suggesting a qualitative shift in stem-like subpopulations rather than a global suppression of cancer stemness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings identify ESRP2 as a key post-transcriptional regulator that constrains EMT-associated transcriptional programs linked to ZEB1 expression, thereby stabilizing epithelial identity in bladder cancer. Targeting alternative splicing may represent a promising therapeutic strategy to limit tumor aggressiveness and overcome treatment resistance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1764850","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T05:26:19Z","timestamp":1774848379000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["ESRP2 constrains EMT plasticity associated with ZEB1 expression in bladder cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Karolina","family":"Bajdak-Rusinek","sequence":"first","affiliation":[{"name":"Department of Molecular Biology, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Jankowska","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Medical University of Silesia","place":["Katowice, Poland"]},{"name":"Students Scientific Society, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh","family":"Sundararajan","sequence":"additional","affiliation":[{"name":"Cancer Science Institute of Singapore, National University of Singapore","place":["Singapore, Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Siero\u0144","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Diak","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weronika","family":"W\u00f3jtowicz","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Medical University of Silesia","place":["Katowice, Poland"]},{"name":"Students Scientific Society, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina L.","family":"St\u0119pie\u0144","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Fus-Kujawa","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Gutmajster","sequence":"additional","affiliation":[{"name":"Biotechnology Centre, Silesian University of Technology","place":["Gliwice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Wierzbinka","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Medical University of Silesia","place":["Katowice, Poland"]},{"name":"Students Scientific Society, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Zorychta","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Medical University of Silesia","place":["Katowice, Poland"]},{"name":"Students Scientific Society, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: A review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"EAU guidelines on non\u2013muscle-invasive bladder cancer (TaT1 and CIS)","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrm3758","article-title":"Revisiting epithelial\u2013mesenchymal transition in cancer metastasis","volume":"11","author":"Lamouille","year":"2014","journal-title":"Mol Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2019.04.010","article-title":"Epithelial-mesenchymal plasticity in cancer progression and metastasis","volume":"49","author":"Lu","year":"2019","journal-title":"Dev Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat Rev Cancer."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2976","article-title":"Oncogenic roles of EMT-inducing transcription factors","volume":"16","author":"Puisieux","year":"2014","journal-title":"Nat Cell Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2010.195","article-title":"An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition","volume":"29","author":"Warzecha","year":"2010","journal-title":"EMBO J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105205","article-title":"The global protein\u2013RNA interaction map of ESRP1 defines a post-transcriptional programme that is essential for epithelial cell function","volume":"25","author":"Peart","year":"2022","journal-title":"iScience."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.01.029","article-title":"Widespread expansion of protein interaction capabilities by alternative splicing","volume":"164","author":"Yang","year":"2016","journal-title":"Cell."},{"key":"B13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.molcel.2009.01.025","article-title":"ESRP1 and ESRP2 are epithelial cell type\u2013specific regulators of FGFR2 splicing","volume":"33","author":"Warzecha","year":"2009","journal-title":"Mol Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI44540","article-title":"CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression","volume":"121","author":"Brown","year":"2011","journal-title":"J Clin Invest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrm1004","article-title":"CD44: from adhesion molecules to signalling regulators","volume":"4","author":"Ponta","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2010.1","article-title":"An ESRP-regulated splicing programme is abrogated during the epithelial\u2013mesenchymal transition","volume":"29","author":"Warzecha","year":"2010","journal-title":"EMBO J"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153999","article-title":"Alternative splicing events and their clinical significance in colorectal cancer: targeted therapeutic opportunities","volume":"15","author":"Manabile","year":"2023","journal-title":"Cancers."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"B20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13073-019-0669-z","article-title":"Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis","volume":"11","author":"de Jong","year":"2019","journal-title":"Genome Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju290","article-title":"Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer","volume":"106","author":"Mitra","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201404208","article-title":"Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients","volume":"6","author":"Tan","year":"2014","journal-title":"EMBO Mol Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial\u2013mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-009-9194-7","article-title":"Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer","volume":"28","author":"McConkey","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.128","article-title":"Multilayer control of the EMT master regulators","volume":"33","author":"Zheng","year":"2014","journal-title":"Oncogene."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-021-01321-x","article-title":"The role of epithelial\u2013mesenchymal transition-regulating transcription factors in anti-cancer drug resistance","volume":"44","author":"Seo","year":"2021","journal-title":"Arch Pharm Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-013-1379-0","article-title":"Posttranscriptional regulation by RNAbinding proteins during epithelial-mesenchymal transition","volume":"70","author":"Aparicio","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41392-024-01734-2","article-title":"Alternative splicing and related RNA binding proteins in human health and disease","volume":"9","author":"Tao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.493","article-title":"TGF-\u03b2 drives epithelial-mesenchymal transition through \u03b4EF1-mediated downregulation of ESRP","volume":"31","author":"Horiguchi","year":"2012","journal-title":"Oncogene."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1402350","article-title":"Alternative splicing regulation and its therapeutic potential in bladder cancer","volume":"14","author":"Li","year":"2024","journal-title":"Front Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e08954","DOI":"10.7554\/eLife.08954","article-title":"The splicing regulators Esrp1 and Esrp2 direct an epithelial splicing program essential for epidermal development","volume":"4","author":"Bebee","year":"2015","journal-title":"eLife."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2018.04.012","article-title":"Epithelial splicing regulatory protein 1 inhibits the invasion and metastasis of lung adenocarcinoma","volume":"188","author":"Li","year":"2018","journal-title":"Am J Pathol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.589432","article-title":"Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via distinct mechanisms","volume":"289","author":"Ishii","year":"2014","journal-title":"J Biol Chem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02838-9","article-title":"Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer","volume":"42","author":"Advani","year":"2023","journal-title":"Oncogene."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e2305653","DOI":"10.1002\/advs.202305653","article-title":"Loss of ESRP2 activates TAK1-MAPK signaling through the fetal RNA-splicing program to promote hepatocellular carcinoma progression","volume":"11","author":"Yan","year":"2024","journal-title":"Adv Sci (Weinh)."},{"key":"B36","article-title":"Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression","volume":"53","author":"Wielenga","year":"1993","journal-title":"Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29642","article-title":"A self-enforcing CD44s\/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells","volume":"137","author":"Preca","year":"2015","journal-title":"Int J Cancer."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.397125","article-title":"Snail represses the splicing regulator ESRP1 to promote the mesenchymal cell state","volume":"287","author":"Reinke","year":"2012","journal-title":"J Cell Science 125(14) 3181\u20133188. https:\/\/doi.org\/10.1242\/jcs.101758. J Biol Chem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/s41467-020-15171-6","article-title":"Full-length transcript characterization of SF3B1 mutation in chronic lymphocytic leukemia reveals downregulation of retained introns","volume":"11","author":"Tang","year":"2020","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1161273","article-title":"Downregulated ESRP1\/2 promotes lung metastasis of bladder cancer through altering FGFR2 splicing and macrophage polarization","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2020.08.034","article-title":"Development and validation of a RNA-binding protein-based prognostic model for bladder cancer","volume":"112","author":"Gao","year":"2020","journal-title":"Genomics."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e1476","DOI":"10.1002\/wrna.1476","article-title":"Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics","volume":"9","author":"Urbanski","year":"2018","journal-title":"Wiley Interdiscip Rev RNA."},{"key":"B43","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-021-00486-7","article-title":"Alternative splicing and cancer: a systematic review","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03279-w","article-title":"Targeting RNA splicing modulation: new perspectives for anticancer strategy","volume":"44","author":"Lv","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.molmed.2015.11.001","article-title":"Small molecule modulators of pre-mRNA splicing in cancer therapy","volume":"22","author":"Salton","year":"2016","journal-title":"Trends Mol Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nm.4493","article-title":"H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers","volume":"24","author":"Seiler","year":"2018","journal-title":"Nat Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.02.014","article-title":"Splice modulating therapies for human disease","volume":"148","author":"Spitali","year":"2012","journal-title":"Cell."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147835","article-title":"A regulatory axis between epithelial splicing regulatory proteins and estrogen receptor \u03b1 Modulates the alternative transcriptome of luminal breast cancer","volume":"23","author":"Elhasnaoui","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1764850\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T05:26:21Z","timestamp":1774848381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1764850\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":48,"alternative-id":["10.3389\/fonc.2026.1764850"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1764850","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"article-number":"1764850"}}